Data collection is the best way for spine surgeons to prepare for success in the future. Hospitals and physicians are already reporting quality data to Medicare that's reported publicly. Cost data isn't far behind as payers and patients are engaging in more cost-comparisons to decide where they'll spend their healthcare dollars.
NuVasive's fourth quarter and full year revenue increased for 2015, and the company completed a key acquisition to boost 2016 financial performance.
A new article posted in Spine compares spinal fusion and growing rods for progressive idiopathic scoliosis patients.
NuVasive named two new members to their board of directors.
There are two new economic publications showing the cost-effectiveness of minimally invasive sacroiliac joint fusion with SI-BONE's iFuse Implant System.
A new study published in the Journal of Neurosurgery: Spine examines isolated cervical facet fractures.
Obtaining reimbursement for new spine surgery technology isn't a walk in the park. There are instances where a new technology receives FDA clearance, support from spine societies, a Category 1 CPT code and coverage by Medicare and Medicaid, and a number of articles detailing clinical evidence supporting use of the technology is published, yet commercial insurance companies still question the procedure.
Stryker plans to acquire Synergetics USA's neuro portfolio.
Research from Finn Partners shows patients are becoming a more vital part of healthcare economics, as reported in Drug Store News. They are more educated consumers and aren't afraid to cost- and quality-compare for their care.
A new study published in the Journal of Spinal Disorders and Techniques examines adjacent segment degeneration and disease after lumbar spinal fusion.